Global Antibiotic Resistance Market Insights, Forecast to 2025

Publisher Name :
Date: 10-May-2019
No. of pages: 112
Inquire Before Buying

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

The global Antibiotic Resistance market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibiotic Resistance market based on company, product type, end user and key regions.

This report studies the global market size of Antibiotic Resistance in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibiotic Resistance in these regions.

This research report categorizes the global Antibiotic Resistance market by top players/brands, region, type and end user. This report also studies the global Antibiotic Resistance market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Allergan

- AmpliPhi Biosciences

- BioVersys GmbH

- Macrolide Pharmaceuticals

- Melinta Therapeutics

- Merck

- Nabriva Therapeutics

- Nemesis Bioscience

- Phage Technologies S.A

- Tetraphase Pharmaceuticals

- The Medicines Company

- TPfizer

- Westway Health

Antibiotic Resistance market size by Type

- By Disease

- - Urinary Tract Infection

- - Intra-Abdominal Infections

- - Blood Stream Infections

- - Clostridium Difficile Infections

- - Acute Bacterial Skin and Skin Structure Infections

- - Bacterial Pneumonia

- By Pathogen

- - Carbapenem-Resistant

- - Carbapenem-Resistant

- - Methicillin-Resistant

- - Carbapenem-Resistant

- - Penicillin-Non-Susceptible

- - Cephalosporin-Resistant

- - Tetracycline-Resistant

- - Vancomycin-Resistant

- - Ampicillin-Resistant

Antibiotic Resistance market size by Applications

- Oxazolidinones

- Lipoglycopeptides

- Tetracyclines

- Cephalosporins

- Combination therapies

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - Turkey

- - GCC Countries

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Antibiotic Resistance market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Antibiotic Resistance market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Antibiotic Resistance companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Antibiotic Resistance submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antibiotic Resistance are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibiotic Resistance market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Antibiotic Resistance Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Antibiotic Resistance Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibiotic Resistance Market Size Growth Rate by Type
1.4.2 Urinary Tract Infection
1.4.3 Intra-Abdominal Infections
1.4.4 Blood Stream Infections
1.4.5 Clostridium Difficile Infections
1.4.6 Acute Bacterial Skin and Skin Structure Infections
1.4.7 Bacterial Pneumonia
1.5 Market by Application
1.5.1 Global Antibiotic Resistance Market Size Growth Rate by Application
1.5.2 Oxazolidinones
1.5.3 Lipoglycopeptides
1.5.4 Tetracyclines
1.5.5 Cephalosporins
1.5.6 Combination therapies
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibiotic Resistance Market Size
2.1.1 Global Antibiotic Resistance Revenue 2014-2025
2.1.2 Global Antibiotic Resistance Sales 2014-2025
2.2 Antibiotic Resistance Growth Rate by Regions
2.2.1 Global Antibiotic Resistance Sales by Regions
2.2.2 Global Antibiotic Resistance Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibiotic Resistance Sales by Manufacturers
3.1.1 Antibiotic Resistance Sales by Manufacturers
3.1.2 Antibiotic Resistance Sales Market Share by Manufacturers
3.2 Antibiotic Resistance Revenue by Manufacturers
3.2.1 Antibiotic Resistance Revenue by Manufacturers (2014-2019)
3.2.2 Antibiotic Resistance Revenue Share by Manufacturers (2014-2019)
3.3 Antibiotic Resistance Price by Manufacturers
3.4 Antibiotic Resistance Manufacturing Base Distribution, Product Types
3.4.1 Antibiotic Resistance Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibiotic Resistance Product Type
3.4.3 Date of International Manufacturers Enter into Antibiotic Resistance Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Antibiotic Resistance Sales by Type
4.2 Global Antibiotic Resistance Revenue by Type
4.3 Antibiotic Resistance Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Antibiotic Resistance Breakdown Data by Application
6 North America
6.1 North America Antibiotic Resistance by Country
6.1.1 North America Antibiotic Resistance Sales by Country
6.1.2 North America Antibiotic Resistance Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibiotic Resistance by Type
6.3 North America Antibiotic Resistance by Application
7 Europe
7.1 Europe Antibiotic Resistance by Country
7.1.1 Europe Antibiotic Resistance Sales by Country
7.1.2 Europe Antibiotic Resistance Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibiotic Resistance by Type
7.3 Europe Antibiotic Resistance by Application
8 Asia Pacific
8.1 Asia Pacific Antibiotic Resistance by Country
8.1.1 Asia Pacific Antibiotic Resistance Sales by Country
8.1.2 Asia Pacific Antibiotic Resistance Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibiotic Resistance by Type
8.3 Asia Pacific Antibiotic Resistance by Application
9 Central & South America
9.1 Central & South America Antibiotic Resistance by Country
9.1.1 Central & South America Antibiotic Resistance Sales by Country
9.1.2 Central & South America Antibiotic Resistance Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Antibiotic Resistance by Type
9.3 Central & South America Antibiotic Resistance by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibiotic Resistance by Country
10.1.1 Middle East and Africa Antibiotic Resistance Sales by Country
10.1.2 Middle East and Africa Antibiotic Resistance Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibiotic Resistance by Type
10.3 Middle East and Africa Antibiotic Resistance by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Company Business Overview
11.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Allergan Antibiotic Resistance Products Offered
11.1.5 Allergan Recent Development
11.2 AmpliPhi Biosciences
11.2.1 AmpliPhi Biosciences Company Details
11.2.2 Company Business Overview
11.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AmpliPhi Biosciences Antibiotic Resistance Products Offered
11.2.5 AmpliPhi Biosciences Recent Development
11.3 BioVersys GmbH
11.3.1 BioVersys GmbH Company Details
11.3.2 Company Business Overview
11.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.3.4 BioVersys GmbH Antibiotic Resistance Products Offered
11.3.5 BioVersys GmbH Recent Development
11.4 Macrolide Pharmaceuticals
11.4.1 Macrolide Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products Offered
11.4.5 Macrolide Pharmaceuticals Recent Development
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Melinta Therapeutics Antibiotic Resistance Products Offered
11.5.5 Melinta Therapeutics Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck Antibiotic Resistance Products Offered
11.6.5 Merck Recent Development
11.7 Nabriva Therapeutics
11.7.1 Nabriva Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Nabriva Therapeutics Antibiotic Resistance Products Offered
11.7.5 Nabriva Therapeutics Recent Development
11.8 Nemesis Bioscience
11.8.1 Nemesis Bioscience Company Details
11.8.2 Company Business Overview
11.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Nemesis Bioscience Antibiotic Resistance Products Offered
11.8.5 Nemesis Bioscience Recent Development
11.9 Phage Technologies S.A
11.9.1 Phage Technologies S.A Company Details
11.9.2 Company Business Overview
11.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Phage Technologies S.A Antibiotic Resistance Products Offered
11.9.5 Phage Technologies S.A Recent Development
11.10 Tetraphase Pharmaceuticals
11.10.1 Tetraphase Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Products Offered
11.10.5 Tetraphase Pharmaceuticals Recent Development
11.11 The Medicines Company
11.12 TPfizer
11.13 Westway Health
12 Future Forecast
12.1 Antibiotic Resistance Market Forecast by Regions
12.1.1 Global Antibiotic Resistance Sales Forecast by Regions 2019-2025
12.1.2 Global Antibiotic Resistance Revenue Forecast by Regions 2019-2025
12.2 Antibiotic Resistance Market Forecast by Type
12.2.1 Global Antibiotic Resistance Sales Forecast by Type 2019-2025
12.2.2 Global Antibiotic Resistance Revenue Forecast by Type 2019-2025
12.3 Antibiotic Resistance Market Forecast by Application
12.4 North America Antibiotic Resistance Forecast
12.5 Europe Antibiotic Resistance Forecast
12.6 Asia Pacific Antibiotic Resistance Forecast
12.7 Central & South America Antibiotic Resistance Forecast
12.8 Middle East and Africa Antibiotic Resistance Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibiotic Resistance Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Antibiotic Resistance Product Picture
Table Antibiotic Resistance Market Segments
Table Key Manufacturers Antibiotic Resistance Covered
Table Global Antibiotic Resistance Market Size Growth Rate by Type 2019-2025 (K Pcs) & (Million US$)
Figure Global Antibiotic Resistance Sales Market Share by Type in 2018 & 2025
Figure Urinary Tract Infection Product Picture
Table Major Manufacturers of Urinary Tract Infection
Figure Intra-Abdominal Infections Product Picture
Table Major Manufacturers of Intra-Abdominal Infections
Figure Blood Stream Infections Product Picture
Table Major Manufacturers of Blood Stream Infections
Figure Clostridium Difficile Infections Product Picture
Table Major Manufacturers of Clostridium Difficile Infections
Figure Acute Bacterial Skin and Skin Structure Infections Product Picture
Table Major Manufacturers of Acute Bacterial Skin and Skin Structure Infections
Figure Bacterial Pneumonia Product Picture
Table Major Manufacturers of Bacterial Pneumonia
Table Global Antibiotic Resistance Market Size Growth Rate by Application 2019-2025 (K Pcs)
Figure Global Antibiotic Resistance 4900 Sales Market Share by Application in 2018
Figure Oxazolidinones
Figure Lipoglycopeptides
Figure Tetracyclines
Figure Cephalosporins
Figure Combination therapies
Figure Other
Figure Antibiotic Resistance Report Years Considered
Figure Global Antibiotic Resistance Market Size 2014-2025 (Million US$)
Figure Global Antibiotic Resistance Sales 2014-2025 (K Pcs)
Table Global Antibiotic Resistance Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Antibiotic Resistance Sales by Regions 2014-2019 (K Pcs)
Table Global Antibiotic Resistance Sales Market Share by Regions 2014-2019
Figure Global Antibiotic Resistance Sales Market Share by Regions 2014-2019
Figure 2018 Global Antibiotic Resistance Sales Market Share by Regions
Table Global Antibiotic Resistance Revenue by Regions 2014-2019 (Million US$)
Table Global Antibiotic Resistance Revenue Market Share by Regions 2014-2019
Figure Global Antibiotic Resistance Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antibiotic Resistance Revenue Market Share by Regions
Table Global Antibiotic Resistance Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Antibiotic Resistance Sales Share by Manufacturers (2014-2019)
Figure Global Antibiotic Resistance Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antibiotic Resistance Revenue by Manufacturers (2014-2019) (Million USD)
Table Antibiotic Resistance Revenue Share by Manufacturers (2014-2019)
Figure Antibiotic Resistance Value Share by Manufacturers in 2018
Table Key Manufacturers Antibiotic Resistance Price (2014-2019) (USD/Pcs)
Table Antibiotic Resistance Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antibiotic Resistance Product Type
Table Date of International Manufacturers Enter into Antibiotic Resistance Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antibiotic Resistance Sales by Type (2014-2019) (K Pcs)
Table Global Antibiotic Resistance Sales Share by Type (2014-2019)
Figure Global Antibiotic Resistance Sales Market Share by Type (2014-2019)
Figure Global Antibiotic Resistance Sales Market Share by Type in 2018
Table Global Antibiotic Resistance Revenue by Type (2014-2019) (Million US$)
Table Global Antibiotic Resistance Revenue Share by Type (2014-2019)
Figure Global Antibiotic Resistance Revenue Market Share by Type (2014-2019)
Figure Global Antibiotic Resistance Revenue Market Share by Type in 2018
Table Antibiotic Resistance Price by Type 2014-2019 (USD/Pcs)
Table Global Antibiotic Resistance Sales by Application (2014-2019) (K Pcs)
Table Global Antibiotic Resistance Sales Share by Application (2014-2019)
Figure Global Sales Antibiotic Resistance Market Share by Application (2014-2019)
Figure Global Sales Antibiotic Resistance Market Share by Application in 2018
Figure North America Antibiotic Resistance Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Antibiotic Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antibiotic Resistance Sales by Country (2014-2019) (K Pcs)
Table North America Antibiotic Resistance Sales Market Share by Country (2014-2019)
Figure 2018 North America Antibiotic Resistance Sales Market Share by Country
Table North America Antibiotic Resistance Revenue by Country (2014-2019) (Million US$)
Table North America Antibiotic Resistance Revenue Market Share by Country (2014-2019)
Figure 2018 North America Antibiotic Resistance Revenue Market Share by Country
Figure United States Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Antibiotic Resistance Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antibiotic Resistance Sales by Type (2014-2019) (K Pcs)
Table North America Antibiotic Resistance Sales Market Share by Type (2014-2019)
Figure 2018 North America Antibiotic Resistance Market Share by Type
Table North America Antibiotic Resistance Sales by Application (2014-2019) (K Pcs)
Table North America Antibiotic Resistance Sales Market Share by Application (2014-2019)
Figure 2018 North America Antibiotic Resistance Market Share by Application
Figure Europe Antibiotic Resistance Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Antibiotic Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antibiotic Resistance Sales by Country (2014-2019) (K Pcs)
Table Europe Antibiotic Resistance Sales Market Share by Country (2014-2019)
Figure 2018 Europe Antibiotic Resistance Sales Market Share by Country
Table Europe Antibiotic Resistance Revenue by Country (2014-2019) (Million US$)
Table Europe Antibiotic Resistance Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Antibiotic Resistance Revenue Market Share by Country
Figure Germany Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure France Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antibiotic Resistance Sales by Type (2014-2019) (K Pcs)
Table Europe Antibiotic Resistance Sales Market Share by Type (2014-2019)
Figure 2018 Europe Antibiotic Resistance Market Share by Type
Table Europe Antibiotic Resistance Sales by Application (2014-2019) (K Pcs)
Table Europe Antibiotic Resistance Sales Market Share by Application (2014-2019)
Figure 2018 Europe Antibiotic Resistance Market Share by Application
Figure Asia Pacific Antibiotic Resistance Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Antibiotic Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antibiotic Resistance Sales by Country (2014-2019) (K Pcs)
Table Asia Pacific Antibiotic Resistance Sales Market Share by Country (2014-2019)
Figure 2018 Asia Pacific Antibiotic Resistance Sales Market Share by Country
Table Asia Pacific Antibiotic Resistance Revenue by Country (2014-2019) (Million US$)
Table Asia Pacific Antibiotic Resistance Revenue Market Share by Country (2014-2019)
Figure 2018 Asia Pacific Antibiotic Resistance Revenue Market Share by Country
Figure China Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure China Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure India Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antibiotic Resistance Sales by Type (2014-2019) (K Pcs)
Table Asia Pacific Antibiotic Resistance Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Antibiotic Resistance Market Share by Type
Table Asia Pacific Antibiotic Resistance Sales by Application (2014-2019) (K Pcs)
Table Asia Pacific Antibiotic Resistance Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Antibiotic Resistance Market Share by Application
Figure Central & South America Antibiotic Resistance Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Antibiotic Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antibiotic Resistance Sales by Country (2014-2019) (K Pcs)
Table Central & South America Antibiotic Resistance Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Antibiotic Resistance Sales Market Share by Country
Table Central & South America Antibiotic Resistance Revenue by Country (2014-2019) (Million US$)
Table Central & South America Antibiotic Resistance Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Antibiotic Resistance Revenue Market Share by Country
Figure Brazil Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antibiotic Resistance Sales by Type (2014-2019) (K Pcs)
Table Central & South America Antibiotic Resistance Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Antibiotic Resistance Market Share by Type
Table Central & South America Antibiotic Resistance Sales by Application (2014-2019) (K Pcs)
Table Central & South America Antibiotic Resistance Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Antibiotic Resistance Market Share by Application
Figure Middle East and Africa Antibiotic Resistance Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Antibiotic Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antibiotic Resistance Sales by Country (2014-2019) (K Pcs)
Table Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Antibiotic Resistance Sales Market Share by Country
Table Middle East and Africa Antibiotic Resistance Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Antibiotic Resistance Revenue Market Share by Country
Figure GCC Countries Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antibiotic Resistance Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Antibiotic Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antibiotic Resistance Sales by Type (2014-2019) (K Pcs)
Table Middle East and Africa Antibiotic Resistance Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Antibiotic Resistance Market Share by Type
Table Middle East and Africa Antibiotic Resistance Sales by Application (2014-2019) (K Pcs)
Table Middle East and Africa Antibiotic Resistance Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Antibiotic Resistance Market Share by Application
Table Allergan Company Details
Table Allergan Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table AmpliPhi Biosciences Company Details
Table AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table AmpliPhi Biosciences Recent Development
Table BioVersys GmbH Company Details
Table BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioVersys GmbH Recent Development
Table Macrolide Pharmaceuticals Company Details
Table Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Macrolide Pharmaceuticals Recent Development
Table Melinta Therapeutics Company Details
Table Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Melinta Therapeutics Recent Development
Table Merck Company Details
Table Merck Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Nabriva Therapeutics Company Details
Table Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Nabriva Therapeutics Recent Development
Table Nemesis Bioscience Company Details
Table Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Nemesis Bioscience Recent Development
Table Phage Technologies S.A Company Details
Table Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Phage Technologies S.A Recent Development
Table Tetraphase Pharmaceuticals Company Details
Table Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Tetraphase Pharmaceuticals Recent Development
Table The Medicines Company Company Details
Table TPfizer Company Details
Table Westway Health Company Details
Table Global Antibiotic Resistance Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Antibiotic Resistance Sales Market Share Forecast by Regions 2019-2025
Table Global Antibiotic Resistance Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antibiotic Resistance Revenue Market Share Forecast by Regions 2019-2025
Table Global Antibiotic Resistance Sales Forecast by Type 2019-2025 (K Pcs)
Table Global Antibiotic Resistance Sales Market Share Forecast by Type 2019-2025
Table Global Antibiotic Resistance Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Antibiotic Resistance Revenue Market Share Forecast by Type 2019-2025
Table Global Antibiotic Resistance Sales Forecast by Application 2019-2025 (K Pcs)
Table Global Antibiotic Resistance Sales Market Share Forecast by Application 2019-2025
Figure North America Antibiotic Resistance Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Antibiotic Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antibiotic Resistance Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Antibiotic Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antibiotic Resistance Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Antibiotic Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antibiotic Resistance Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Antibiotic Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antibiotic Resistance Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Antibiotic Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Antibiotic Resistance Value Chain
Table Antibiotic Resistance Customers List
Figure Channels of Distribution
Table Antibiotic Resistance Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs